A multicenter, placebo-controlled, dose-ranging study of atorvastatin

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 3, Issue 2, 1998, Pages 119-124

  Schrott, H ^a   Fereshetian, A G ^a   Knopp, R H ^a   Bays, H ^a   Jones, P H ^a   Littlejohn III, T W ^a   McLain, R ^a   Black, D M ^a  

^a PFIZER INC   (United States)

Author keywords

Atorvastatin; Coronary heart disease; LDL cholesterol

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032464095     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424849800300204     Document Type: Article

References (16)